National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 7725-7726 [2024-02219]

Download as PDF 7725 Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total burden hours Performance Improvement and Measurement Systems (PIMS) .............................................................................. 21 1 21 8 168 Total .............................................................................. 21 1 21 8 168 HRSA specifically requests comments on: (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–02242 Filed 2–2–24; 8:45 am] Health, 5601 Fishers Lane, Room 3G56, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Maryam Rohani, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD 20852, (301) 761–6656, maryam.rohani@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 30, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2024–02152 Filed 2–2–24; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. lotter on DSK11XQN23PROD with NOTICES1 Total responses Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; PAR–23–065, NIAID Resource Related Research Projects (R24 Clinical Trial Not Allowed). Date: February 29, 2024. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of VerDate Sep<11>2014 17:56 Feb 02, 2024 Jkt 262001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892. Contact Person: Sheila Pirooznia, Ph.D., Scientific Review Officer, Division of Extramural Review, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 496–9350, sheila.pirooznia@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: January 30, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–02154 Filed 2–2–24; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity. Date: March 28, 2024. Time: 10:30 a.m. to 6:00 p.m. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\05FEN1.SGM 05FEN1 7726 Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Translational and Brain Devices Panel. Date: February 21, 2024. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: M. Catherine Bennett, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH/HHS NSC, 6001 Executive Boulevard, Rockville, MD 20852, 301–435–1766, bennettc3@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS.) Dated: January 31, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–02219 Filed 2–2–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health lotter on DSK11XQN23PROD with NOTICES1 National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Advisory Board, February 8, 2024, 05:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Bethesda, MD 20892 (Virtual Meeting) which was published in the Federal Register on November 7, 2023, FR Doc 2023–24578, 88 FR 76836. This meeting notice is being amended to change the times for the National Cancer Advisory Board (NCAB) Subcommittee Meetings, Open Session, and Closed Session on February 8, 2024. The NCAB Subcommittee Meetings will now be held from 10:00 a.m. to 1:10 p.m. instead of from 11:00 a.m. to 1:05 p.m. The NCAB Open Session will now be held from 1:15 p.m. to 4:15 p.m. instead of from 1:15 p.m. to 3:30 p.m. The NCAB Closed Session will now be held from 4:25 p.m. to 5:30 p.m. instead of from 3:30 p.m. to 5:00 p.m. The NCAB Subcommittee Meetings and NCAB Open Session can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. The meeting is partially Closed to the public. VerDate Sep<11>2014 17:56 Feb 02, 2024 Jkt 262001 Dated: January 31, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–02222 Filed 2–2–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR Geological Survey [GX24EN05ESBJF00] Public Meeting of the Advisory Council for Climate Adaptation Science U.S. Geological Survey, Department of the Interior. ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act (FACA) of 1972, the U.S. Geological Survey (USGS) is publishing this notice to announce that a Federal advisory committee meeting of the Advisory Council for Climate Adaptation Science (ACCAS) will take place and is open to members of the public. DATES: The meeting will be held in person on Tuesday, February 27, 2024, from 8:30 a.m. to 5 p.m., and on Wednesday, February 28, 2024, from 8:30 a.m. to 3 p.m. eastern standard time. A virtual option for attendance will be provided. The final schedule will be made available in advance of the meeting at: https://www.usgs.gov/ programs/climate-adaptation-sciencecenters/advisory-council-climateadaptation-science. ADDRESSES: The meeting will be held at the Stewart Lee Udall Department of the Interior Building, 1849 C Street NW, Conference Room 5160, Washington, DC 20240. FOR FURTHER INFORMATION CONTACT: Holly Chandler, ACCAS Designated Federal Officer, USGS, by email at casc@usgs.gov or by telephone at (406) 207–9500. SUPPLEMENTARY INFORMATION: This meeting is being held consistent with the provisions of the FACA (5 U.S.C. ch. 10), the Government in the Sunshine Act of 1976 (5 U.S.C. 552B, as amended), and 41 CFR part 102–3. Purpose of the Meeting: The ACCAS advises the Secretary of the Interior on the operations of the USGS Climate Adaptation Science Centers (CASCs). ACCAS members represent State and local governments; Tribes and Indigenous organizations; nongovernmental organizations; academia; and the private sector. Additional information about the ACCAS is available at: https://www.usgs.gov/ SUMMARY: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 programs/climate-adaptation-sciencecenters/advisory-council-climateadaptation-science. Agenda Topics: Agenda topics will cover background information about the CASCs; the development of priorities and a workplan for the ACCAS; and discussion of possible ACCAS subcommittees. The final agenda will be made available in advance of the meeting at: https://www.usgs.gov/ programs/climate-adaptation-sciencecenters/advisory-council-climateadaptation-science. The meeting will include opportunities for public comment on February 27 and 28. Comments may also be submitted to ACCAS by email to casc@usgs.gov. Meeting Accessibility/Special Accommodations: The meeting is open to the public; however, seating may be limited due to room capacity. A virtual option for attendance will be provided to those who register. Public attendees should register by completing this form: https://www.usgs.gov/programs/climateadaptation-science-centers/advisorycouncil-climate-adaptation-science. Registrations are due by February 20, 2024. Please make requests in advance for sign-language interpreter services, assistive listening devices, or other reasonable accommodations. We ask that you contact casc@usgs.gov at least seven (7) business days prior to the meeting to give the Department of the Interior sufficient time to process your request. All reasonable accommodation requests are managed on a case-by-case basis. Individuals in the United States who are deaf, blind, hard of hearing, or have a speech disability may dial 711 (TTY, TDD, or TeleBraille) to access telecommunications relay services. Individuals outside the United States should use the relay services offered within their country to make international calls to the point-ofcontact in the United States. Public Disclosure of Comments: There will be an opportunity for public comment during the meeting. Depending on the number of people who wish to speak and the time available, the time for individual comments may be limited. Written comments may also be sent to the ACCAS for consideration. To allow for full consideration of information by ACCAS members, written comments must be provided by email to casc@ usgs.gov at least three (3) business days prior to the meeting. Before including your address, phone number, email address, or other personally identifiable information (PII) in your comment, you should be aware E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Pages 7725-7726]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 7726]]


    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Translational and Brain Devices 
Panel.
    Date: February 21, 2024.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: M. Catherine Bennett, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/HHS NSC, 6001 Executive Boulevard, Rockville, 
MD 20852, 301-435-1766, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS.)

    Dated: January 31, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02219 Filed 2-2-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.